Search results
Merz wins $185m bid for bankrupt Acorda assets and increases US workforce by 50%
Pharmaceutical Technology· 11 hours agoHowever, in subsequent years, Acorda struggled financially as sales of its drugs weakened. Biogen,...
UniQure stock surges on data for Huntington’s gene therapy
BioPharma Dive· 3 days agoThe biotech’s stock rose more than 60% as fresh data appeared to alleviate some investor concerns...
Polpharma looks to challenge Takeda’s Entyvio in IBD
Pharmaceutical Technology· 4 days agoAnother biosimilar developed by Polpharma is Biogen’s Tysabri (natalizumab) biosimilar, Tyruko. The biosimilar is licensed to Sandoz, which bears...
Biogen Pharmachem Industries - Closure of Trading Window
CNBC Awaaz· 6 days agoBiogen Pharmachem Industries - Closure of Trading Window